Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/42880
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBelkhouribchia, Jamal-
dc.date.accessioned2024-05-08T07:58:41Z-
dc.date.available2024-05-08T07:58:41Z-
dc.date.issued2024-
dc.date.submitted2024-04-25T06:55:34Z-
dc.identifier.citationNEW ENGLAND JOURNAL OF MEDICINE, 390 (8) , p. 767-
dc.identifier.urihttp://hdl.handle.net/1942/42880-
dc.language.isoen-
dc.publisherMASSACHUSETTS MEDICAL SOC-
dc.subject.otherHumans-
dc.subject.otherObesity-
dc.subject.otherGlucagon-Like Peptides-
dc.subject.otherDiabetes Mellitus, Type 2-
dc.titleSemaglutide and Cardiovascular Outcomes-
dc.typeJournal Contribution-
dc.identifier.issue8-
dc.identifier.spage767-
dc.identifier.volume390-
local.format.pages1-
local.bibliographicCitation.jcatA1-
dc.description.notesBelkhouribchia, J (corresponding author), Endocrinol Ctr, Hasselt, Belgium.-
local.publisher.placeWALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1056/NEJMc2400414-
dc.identifier.pmid38381684-
dc.identifier.isi001185614100002-
local.provider.typewosris-
local.description.affiliation[Belkhouribchia, Jamal] Endocrinol Ctr, Hasselt, Belgium.-
local.uhasselt.internationalno-
item.fulltextNo Fulltext-
item.contributorBelkhouribchia, Jamal-
item.accessRightsClosed Access-
item.fullcitationBelkhouribchia, Jamal (2024) Semaglutide and Cardiovascular Outcomes. In: NEW ENGLAND JOURNAL OF MEDICINE, 390 (8) , p. 767.-
crisitem.journal.issn0028-4793-
crisitem.journal.eissn1533-4406-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.